Please assess the completion status of the following clinical trial:

Trial Title: Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Females of reproductive age with regular menstrual cycles and a diagnosis of von Willebrand disease according to the International Society of Thrombosis and Hemostasis diagnostic criteria.~Exclusion Criteria:~* Females who are pregnant, or have a history of endocrinopathy or hormone imbalance~* History of hysterectomy or bilateral oophorectomy~* History of ovarian or uterine cancer~* Use of intrauterine device~* Use of antifibrinolytic therapy, hemostatic agents, or anti-platelet agents.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).